Medication adherence and significant others' support of consumers with schizophrenia in Australia

被引:10
|
作者
McCann, Terence V. [1 ]
Lu, Sai [1 ]
机构
[1] Victoria Univ, Sch Nursing & Midwifery, Melbourne, Vic 8001, Australia
关键词
consumers; medication adherence; schizophrenia; significant other support; survey; ANTIPSYCHOTIC MEDICATION; SOCIAL SUPPORT; 1ST EPISODE; PREDICTORS; NONADHERENCE; INTERVENTIONS; HEALTH; RISK; ADOLESCENTS;
D O I
10.1111/j.1442-2018.2009.00440.x
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Medication adherence is problematic in people with chronic illness. The purpose of this exploratory study was to examine the effects of the perceived support from significant others on the oral antipsychotic medication taking of consumers with schizophrenia. A convenience sample of 81 consumers took part in the study. The consumers were recruited by case managers from the community in the western region of Melbourne and in regional and rural Victoria, Australia. No difference was found in self-reported medication adherence between the consumers with significant others' support and those without significant others' support. The perceived effect of having a supportive relationship with significant others was not associated with increased medication adherence. The findings indicated that the significant others' support did not influence the self-reported medication adherence of the consumers with schizophrenia. The results highlighted the importance of considering medication adherence as a multidimensional concept.
引用
收藏
页码:228 / 234
页数:7
相关论文
共 50 条
  • [1] A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia
    Boardman, Gayelene
    McCann, Terence
    Kerr, Debra
    JOURNAL OF ADVANCED NURSING, 2014, 70 (10) : 2293 - 2302
  • [2] Does peer support improve consumers' medication adherence?
    Boardman, Gayelene
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2010, 19 : A4 - A4
  • [3] Medication adherence in schizophrenia
    Fatma, F.
    Baati, I.
    Omri, S.
    Sallemi, R.
    Masmoudi, J.
    EUROPEAN PSYCHIATRY, 2016, 33 : S586 - S586
  • [4] Medication adherence in schizophrenia
    Javier Acosta, Francisco
    Luis Hernandez, Jose
    Pereira, Jose
    Herrera, Judit
    Rodriguez, Carlos J.
    WORLD JOURNAL OF PSYCHIATRY, 2012, 2 (05): : 74 - 82
  • [5] Strategies to improve medication adherence in patients with schizophrenia: the role of support services
    El-Mallakh, Peggy
    Findlay, Jan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1077 - 1090
  • [6] BEGINNING SCHIZOPHRENIA OBSERVED BY SIGNIFICANT OTHERS
    HAMBRECHT, M
    HAFNER, H
    LOFFLER, W
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1994, 29 (02) : 53 - 60
  • [7] Medication adherence in patients with schizophrenia
    Renemane, L.
    Kupca, B.
    Huncaka, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S564 - S564
  • [8] Antipsychotic medication adherence in schizophrenia
    Byerly, Matthew J.
    Nakonezny, Paul A.
    Lescouflair, Emmeline
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2007, 30 (03) : 437 - +
  • [9] Medication adherence in patients with schizophrenia
    Phan, Stephanie V.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2016, 51 (02): : 211 - 219
  • [10] The cost of relapse in schizophrenia patients due to partial adherence to medication in Australia; A retrospective audit
    Kulkarni, J
    Arya, DK
    Fitzgerald, P
    de Castella, A
    Meere, S
    Crowley, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S217 - S217